Literature DB >> 18299172

REM sleep behaviour disorder treated with melatonin in a patient with Alzheimer's disease.

Kirstie N Anderson1, Sarah Jamieson, Andrew J Graham, John M Shneerson.   

Abstract

We report a case of a 68-year-old man with probable Alzheimer's disease who developed rapid eye movement (REM) sleep behaviour disorder. This was confirmed with polysomnography but the patient also had some sleep apnea, which prevented the use of clonazepam for treatment. Melatonin was successfully used as an alternative treatment.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18299172     DOI： 10.1016/j.clineuro.2008.01.004

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN： 0303-8467            Impact factor:   1.876


  6 in total

Review 1.  Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.

Authors:  Seithikurippu R Pandi-Perumal; Ahmed S BaHammam; Gregory M Brown; D Warren Spence; Vijay K Bharti; Charanjit Kaur; Rüdiger Hardeland; Daniel P Cardinali
Journal:  Neurotox Res       Date:  2012-06-28       Impact factor: 3.911

2.  Best practice guide for the treatment of REM sleep behavior disorder (RBD).

Authors:  R Nisha Aurora; Rochelle S Zak; Rama K Maganti; Sanford H Auerbach; Kenneth R Casey; Susmita Chowdhuri; Anoop Karippot; Kannan Ramar; David A Kristo; Timothy I Morgenthaler
Journal:  J Clin Sleep Med       Date:  2010-02-15       Impact factor: 4.062

3.  Melatonin and its agonist ramelteon in Alzheimer's disease: possible therapeutic value.

Authors:  Venkatramanujam Srinivasan; Charanjit Kaur; Seithikurippu Pandi-Perumal; Gregory M Brown; Daniel P Cardinali
Journal:  Int J Alzheimers Dis       Date:  2010-12-08

4.  Clinical aspects of melatonin intervention in Alzheimer's disease progression.

Authors:  Daniel P Cardinali; Analía M Furio; Luis I Brusco
Journal:  Curr Neuropharmacol       Date:  2010-09       Impact factor: 7.363

Review 5.  Melatonin Therapy in Patients with Alzheimer's Disease.

Authors:  Daniel P Cardinali; Daniel E Vigo; Natividad Olivar; María F Vidal; Luis I Brusco
Journal:  Antioxidants (Basel)       Date:  2014-04-10

6.  Melatonin for rapid eye movement sleep behavior disorder in Parkinson's disease: A randomised controlled trial.

Authors:  Moran Gilat; Alessandra Coeytaux Jackson; Nathaniel S Marshall; Deborah Hammond; Anna E Mullins; Julie M Hall; Bernard A M Fang; Brendon J Yee; Keith K H Wong; Ron R Grunstein; Simon J G Lewis
Journal:  Mov Disord       Date:  2019-10-31       Impact factor: 10.338
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.